Provence Technologies SAS-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Provence Technologies SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014207
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Provence Technologies SAS (ProvenceTech) is a contract research organization that provides fine organic chemistry solutions. The organization’s services include chemical development, analytical development and, global offer and consulting. It also provides research and development services. ProvenceTech offers its services in the fields of phenothiazines, nucleosides, azaindoles, nucleotides, conjugated dienes and heterocyclic chemistries, among others. The organization’s research programs comprise 4 and 7- aza – indoles, methylene blue and pheromones. It develops synthetic pathway to pharmaceutical grade of methylene blue. ProvenceTech is headquartered in Marseille, France.

Provence Technologies SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Provence Technologies SAS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Provence Technologies SAS, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Provence Technologies SAS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Provence Technologies SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Provence Technologies SAS, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Provence Technologies SAS, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Provepharm Partners with DFKC 10
Provepharm Enters Into Distribution Agreement With Fresenius Kabi Pharma 11
Provence Technologies Enters Into Co-Development Agreement With Neuroptis Biotech 12
Provepharm Partners with MARTINDALE PHARMA 13
NexGenix Pharma Enters Into Collaboration With PROVENCE TECHNOLOGIES 14
Licensing Agreements 15
Provepharm Enters Into Licensing Agreement With NordMedica 15
Daiichi Sankyo Enters Into Licensing Agreement With Provepharm For Methylthioninium Chloride Solution For Methaemoglobinaemia 16
Acquisition 17
Provence Acquires Synprosis 17
Provence Technologies SAS – Key Competitors 18
Provence Technologies SAS – Key Employees 19
Provence Technologies SAS – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Provence Technologies SAS, Pharmaceuticals & Healthcare, Key Facts 2
Provence Technologies SAS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Provence Technologies SAS, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Provence Technologies SAS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Provence Technologies SAS, Deals By Therapy Area, 2011 to YTD 2017 8
Provence Technologies SAS, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Provepharm Partners with DFKC 10
Provepharm Enters Into Distribution Agreement With Fresenius Kabi Pharma 11
Provence Technologies Enters Into Co-Development Agreement With Neuroptis Biotech 12
Provepharm Partners with MARTINDALE PHARMA 13
NexGenix Pharma Enters Into Collaboration With PROVENCE TECHNOLOGIES 14
Provepharm Enters Into Licensing Agreement With NordMedica 15
Daiichi Sankyo Enters Into Licensing Agreement With Provepharm For Methylthioninium Chloride Solution For Methaemoglobinaemia 16
Provence Acquires Synprosis 17
Provence Technologies SAS, Key Competitors 18
Provence Technologies SAS, Key Employees 19
Provence Technologies SAS, Subsidiaries 20

★海外企業調査レポート[Provence Technologies SAS-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • VIDA Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary VIDA Diagnostics Inc (VIDA) is a medical technology company that provides clinical imaging software and analysis services for early detection, evaluation, and treatment of pulmonary diseases. The company offers VIDA exchange and VIDA vision. Its products are used in airway mapping, lung volu …
  • Bunzl plc (BNZL):企業の財務・戦略的SWOT分析
    Bunzl plc (BNZL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Spotlight Innovation Inc (STLT):企業の財務・戦略的SWOT分析
    Summary Spotlight Innovation Inc (Spotlight Innovation), formerly American Exploration Corp is a developer of proprietary technologies designed to treat rare, emerging and neglected diseases. The company’s product pipeline includes drug candidates for the treatment of cancer derived from specialized …
  • Kane Biotech Inc (KNE):製薬・医療:M&Aディール及び事業提携情報
    Summary Kane Biotech Inc (Kane Biotech) is a developer of pharmaceutical products that prevent and remove microbial biofilms. The company uses patent protected technology based on molecular mechanisms of biofilm formation and methods for finding compounds that inhibit or disrupt biofilms. It develop …
  • EaglePicher Technologies LLC:企業の戦略的SWOT分析
    EaglePicher Technologies LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Relmada Therapeutics Inc (RLMDD):企業の財務・戦略的SWOT分析
    Summary Relmada Therapeutics Inc (Relmada Therapeutics), formerly Camp Nine Inc, is a pharmaceutical company that develops and commercializes products for the treatment of central nervous system (CNS) diseases. The company’s product pipeline includes REL-1017 d-Methadone, an antagonist for the treat …
  • Royal BAM Group nv:企業の戦略・SWOT・財務分析
    Royal BAM Group nv - Strategy, SWOT and Corporate Finance Report Summary Royal BAM Group nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Mereo Biopharma Group Plc (MPH):企業の財務・戦略的SWOT分析
    Summary Mereo Biopharma Group Plc (Mereo), formerly Mereo Biopharma Group Ltd is a specialty bio-pharmaceutical company which develops novel medicines for the treatment of rare and specialty diseases. The company’s pipeline products include BPS-804, which is used for the treatment of brittle bone sy …
  • MI Bioresearch Inc-医療機器分野:企業M&A・提携分析
    Summary MI Bioresearch Inc (MI), formerly Molecular Imaging Inc is a research institute that offers pharmacology research services. The institute offers services such as oncology pharmacology, immuno oncology, in vitro services, imaging and radiation. Its oncology pharmacology include subcutaneous m …
  • Aalberts Industries NV:企業のM&A・事業提携・投資動向
    Aalberts Industries NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aalberts Industries NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Cafe De Coral Holdings Limited
    Cafe De Coral Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Cafe De Coral Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Vodafone Group Plc (VOD):企業の財務・戦略的SWOT分析
    Vodafone Group Plc (VOD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • EMCOR Group, Inc.:企業の戦略・SWOT・財務情報
    EMCOR Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary EMCOR Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Japan Pulp and Paper Co Ltd:戦略・SWOT・企業財務分析
    Japan Pulp and Paper Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Japan Pulp and Paper Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Formosa Petrochemical Corp (6505):石油・ガス:M&Aディール及び事業提携情報
    Summary Formosa Petrochemical Corp (FPCC) refines crude oil and sells refined petroleum products and olefins. The company operates refinery and integrated petrochemical complexes. It imports, exports, markets, stores, and transports crude oil, gasoline, naphtha, propane and other feed stocks. The co …
  • OraSure Technologies Inc (OSUR):企業の財務・戦略的SWOT分析
    OraSure Technologies Inc (OSUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Nippon Paint (China) Co Ltd:企業の戦略・SWOT・財務分析
    Nippon Paint (China) Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Nippon Paint (China) Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Autoridad del Canal de Panama:企業の戦略的SWOT分析
    Autoridad del Canal de Panama - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • GFT Technologies AG (GFT):企業の財務・戦略的SWOT分析
    Summary GFT Technologies AG (GFT Technologies) is a technology company that implements, develops, and maintains information technology solutions. The company’s services comprise application management, bespoke development, product based implementation, and business and IT consultation services. It a …
  • H2O Innovation Inc (HEO):企業の財務・戦略的SWOT分析
    Summary H2O Innovation Inc (H2O Innovation) is a clean technology company that filters, manufactures and markets water and wastewater treatment systems with membrane filtration technologies. The company carries out water treatment solutions for the production of drinking water and industrial process …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆